DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/vdjb3r/antidoping) has announced the addition of Future Science Ltd's new report "Anti-doping Analysis and the Olympics" to their offering.
The fight against doping has always been a contentious one, where the techniques behind its bioanalytical procedures must be robust enough to stand up in both the laboratory and in court. In this special focus issue (volume 4, issue 13), guest edited by both Dr Olivier Rabin (World Anti-Doping Agency) and Dr Patrick Schamasch (International Olympic Committee), topics such as the history of doping analysis and the World Anti-Doping Agency, the current state of the field - including the challenges faced in implementing the Athlete Biological Passport, the use of performance-enhancing drugs such as EPO and peptides, the difficulty in maintaining a balance between regulatory bodies and laboratory approval, as well as the future of this field with respect to new technologies, testing matrices and doping agents are discussed at depth.
From a selection of contributions from experts in both academia and industry, this special focus issues features a range of absorbing articles from Perspectives to Reviews, Special Reports and Editorials, as well as an insightful Interview with the academic and industry leaders of the London 2012 anti-doping laboratory: David Cowan (King's College London) and Campbell Barker (GlaxoSmithKline), who detail the implications and challenges of forming such a unique and novel partnership.
As Dr Rabin and Dr Schamasch explain, The articles contained within this special Olympic issue of Bioanalysis offer an insight into the challenges faced by the anti-doping analysts in the testing procedures of athletes' samples, and examine some of the recent developments made in the science of anti-doping as well as some future perspectives in anti-doping testing.
Key Topics Covered:
NEWS & ANALYSIS
For more information visit http://www.researchandmarkets.com/research/vdjb3r/antidoping
Source: Future Science Ltd